This is a StreetInsider.com Premium Only Page

Coherus BioSciences (CHRS) – StreetInsider.com Reports

Mar 20, 2024 06:39 AM Coherus Biosciences (CHRS) PT Lowered to $11 at H.C. Wainwright

Mar 13, 2024 04:42 PM After-hours movers: UiPath, SentinelOne, Under Armour, and more

Mar 13, 2024 04:16 PM Coherus BioSciences (CHRS) Misses Q4 EPS by 41c, offers guidance

Mar 13, 2024 04:05 PM Coherus BioSciences (CHRS) Misses Q4 EPS by 50c, Misses on Revenue

Mar 13, 2024 04:04 PM Coherus BioSciences (CHRS) to Cut 30% Staff

Feb 22, 2024 05:06 PM Coherus BioSciences (CHRS) Appoints Georgia Erbez to its Board

Jan 23, 2024 06:16 AM Coherus Biosciences (CHRS) PT Lowered to $9 at Baird

Jan 23, 2024 04:41 AM Coherus Biosciences (CHRS) PT Lowered to $7 at Truist Securities

Jan 22, 2024 07:12 AM Sandoz announces agreement to acquire CIMERLI business from Coherus (CHRS)

Jan 18, 2024 04:53 PM After-hours movers: Super Micro Computer, J.B. Hunt, and more

Jan 18, 2024 04:16 PM Coherus (CHRS) Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody

Jan 10, 2024 06:10 AM Coherus BioSciences (CHRS) Announces Termination of TIGIT Program

Jan 10, 2024 06:10 AM Coherus BioSciences (CHRS) Issues 2023 Guidance

Dec 28, 2023 03:14 PM Coherus BioSciences (CHRS) January 3 calls active as share price up 19%

Dec 27, 2023 12:00 PM Midday movers: Tesla, Coinbase, and more

Dec 27, 2023 09:41 AM Increasing unusual option volume: CHRS NTES IOVA CYTK

Dec 27, 2023 07:57 AM Coherus BioSciences (CHRS) surges on FDA Udenyca delivery system approval

Dec 26, 2023 04:03 PM Coherus (CHRS) Announces FDA Approval of UDENYCA ONBODY

Nov 28, 2023 11:17 AM Coherus BioSciences (CHRS) and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02

Nov 17, 2023 04:27 AM Baird Starts Coherus Biosciences (CHRS) at Outperform

Nov 8, 2023 07:17 AM Maxim Group Downgrades Coherus Biosciences (CHRS) to Hold

Nov 7, 2023 07:47 AM Coherus Biosciences (CHRS) PT Lowered to $12 at Truist Securities

Nov 7, 2023 06:33 AM Coherus Biosciences (CHRS) PT Lowered to $13 at H.C. Wainwright

Nov 6, 2023 04:21 PM Coherus BioSciences (CHRS) Tops Q3 EPS by 11c

Oct 30, 2023 08:17 AM McDonald's, Ford, Southwest Airlines rise premarket; Cisco fell

Oct 30, 2023 04:25 AM Coherus Biosciences (CHRS) PT Raised to $14 at Citi

Oct 27, 2023 03:10 PM Coherus BioSciences (CHRS) and Junshi Biosciences Announce FDA Approval of LOQTORZI (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

Oct 23, 2023 03:26 AM Coherus Biosciences (CHRS) PT Lowered to $7 at Barclays

Oct 5, 2023 08:53 AM Coherus (CHRS) Announces Resubmission of BLA Supplement for UDENYCA ONBODY

Sep 25, 2023 08:32 AM Coherus BioSciences (CHRS) Announces FDA Issues CRL for UDENYCA ONBODY Biologics License Application Solely Due to an Ongoing Review of Inspection Findings

Sep 12, 2023 06:14 AM Coherus BioSciences (CHRS) Increases ATM Offering Program by $28.75M

Sep 1, 2023 07:16 PM Blackstone (BX), Airbnb (ABNB) to Join S&P 500

Aug 31, 2023 04:01 PM Surface Oncology (SURF) Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences (CHRS)

Aug 7, 2023 06:46 AM Coherus Biosciences (CHRS) PT Lowered to $7 at UBS

Aug 3, 2023 10:11 AM Coherus Biosciences (CHRS) PT Raised to $13 at Citi

Aug 3, 2023 09:24 AM Coherus Biosciences (CHRS) PT Lowered to $7 at BofA Securities

Aug 3, 2023 06:41 AM Coherus Biosciences (CHRS) PT Lowered to $20 at H.C. Wainwright

Aug 2, 2023 04:13 PM Coherus BioSciences (CHRS) Tops Q2 EPS by 14c, beats revenue

Jul 24, 2023 05:57 AM Citi Starts Coherus Biosciences (CHRS) at Buy, 'Come for the Biosimilars, Stay for the I/O Pipeline'

Jul 14, 2023 07:59 AM Coherus Biosciences (CHRS) PT Lowered to $20 at Truist Securities

Jun 21, 2023 04:52 AM Increasing unusual option volume: CHRS MQ HUN QSR TMC VRT BOTZ RYAM OPCH

Jun 20, 2023 07:35 AM Coherus Biosciences (CHRS) PT Lowered to $22 at Truist Securities

Jun 16, 2023 07:05 AM Coherus (CHRS) to Acquire Surface Oncology (SURF)

Jun 1, 2023 10:48 AM AbbVie (ABBV) declines after Coherus (CHRS) launches Humira biosimilar at 85% discount

Jun 1, 2023 09:34 AM AbbVie (ABBV) Declines After Coherus BioSciences (CHRS) Announces Pact with Mark Cuban for Humira Biosimilar

Jun 1, 2023 08:35 AM Mark Cuban Cost Plus Drug Company joins forces with Coherus (CHRS) to make YUSIMRY, a HUMIRA biosimilar, available to patients

May 25, 2023 07:11 AM Coherus Biosciences (CHRS) PT Lowered to $8 at JPMorgan

May 23, 2023 03:53 AM Coherus Biosciences (CHRS) PT Lowered to $8 at Barclays

May 15, 2023 05:37 PM After-hours movers: Capital One gains on Buffett stake, Ducommun falls on offering

May 15, 2023 04:03 PM Coherus (CHRS) Announces $50M Proposed Public Offering of Common Stock